Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Osteoprotegerin inhibits the d...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
Bibliographic Details
Main Authors:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
Format:
Journal article
Published:
2001
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
by: Croucher, P, et al.
Published: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
by: Croucher, P, et al.
Published: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
by: Croucher, P, et al.
Published: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
by: Croucher, P, et al.
Published: (2001)
Osteoprotegerin and the development of myeloma bone disease
by: Croucher, P, et al.
Published: (2004)